Cargando…
Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives
BACKGROUND: Current vaccination strategies against pertussis are sub-optimal. Optimal protection against Bordetella pertussis, the causative agent of pertussis, likely requires mucosal immunity. Current pertussis vaccines consist of inactivated whole B. pertussis cells or purified antigens thereof,...
Autores principales: | Dubois, Violaine, Locht, Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239240/ https://www.ncbi.nlm.nih.gov/pubmed/34211481 http://dx.doi.org/10.3389/fimmu.2021.701285 |
Ejemplares similares
-
The Role of Mucosal Immunity in Pertussis
por: Solans, Luis, et al.
Publicado: (2019) -
Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023) -
Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021) -
Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases
por: Cauchi, Stéphane, et al.
Publicado: (2018) -
Generating enhanced mucosal immunity against Bordetella pertussis: current challenges and new directions
por: Caulfield, Amanda D., et al.
Publicado: (2023)